|3.||Neoplasm Metastasis (Metastasis)
|4.||Hypercalcemia (Milk Alkali Syndrome)
|1.||Epstein, O I: 1 article (09/2013)|
|2.||Dugina, J L: 1 article (09/2013)|
|3.||Yurlova, E I: 1 article (09/2013)|
|4.||Krylova, S G: 1 article (09/2013)|
|5.||Pereira, Márcio Roberto Pinho: 1 article (09/2012)|
|6.||Soares, Fabiana Pereira: 1 article (09/2012)|
|7.||Silva, Sônia Leite da: 1 article (09/2012)|
|8.||Ribeiro, Thyciana Rodrigues: 1 article (09/2012)|
|9.||Silva, Silvia Fernandes Ribeiro da: 1 article (09/2012)|
|10.||Targino, Thiago Sousa e Silva: 1 article (09/2012)|
10/01/1972 - "[Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics]."
01/01/1970 - "[Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)]."
|2.||Fluorouracil (Carac)FDA LinkGeneric
01/01/1980 - "[Studies in vivo and in vitro on the influence of 5-fluorouracil and n'-(2'-furanidyl)-5-fluorouracil on the walker carcinosarcoma 256 in the rat (author's transl)]."
04/01/1981 - "The antitumor activity of this compound was superior to those of 5-FU and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur, Ftorafur) in the treatment of transplantable tumors, not only 5-FU-sensitive tumors such as adenocarcinoma 755, lymphosarcoma LS-1, and plasmacytoma X5563, but also 5-FU-resistant tumors such as Lewis lung carcinoma and Walker carcinosarcoma 256. "
|3.||Methylene Chloride (Dichloromethane)IBA
|4.||Mechlorethamine (Nitrogen Mustard)FDA Link
|5.||Complement C5 (Complement 5)IBA
|7.||Parathyroid Hormone-Related ProteinIBA
10/21/1992 - "Isolation of a 18,000-Da molecular weight form of parathyroid hormone-related protein from the rat Walker carcinosarcoma 256."
02/01/1991 - "Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP)."
01/01/1995 - "Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model."
05/01/1995 - "Walker carcinoma 256 (W256) was reported to induce hypercalcemia dependent on bone metastasis and/or parathyroid hormone-related protein (PTHrP) in the rat, providing a model of the humoral hypercalcemia of malignancy. "
04/01/1996 - "Glucocorticoids decrease the production of parathyroid hormone-related protein in vitro but not in vivo in the Walker carcinosarcoma 256 rat model."
01/01/1978 - "The compound in high doses was ineffective against the DMBA-induced rat mammary carcinoma and the following transplanted experimental tumors: Sarcoma 180, plasma cell tumor LPC-1, leukemia L1210, Mecca lymphosarcoma, Ridgway osteogenic sarcoma, sarcoma T241, mammary carcinoma E0771, Taper liver tumor, Ehrlich carcinoma (solid and ascites), and Walker carcinosarcoma 256. "
01/01/1980 - "Three new nitrosoureas and chlorozotocin were screened for anticancer activity against Walker carcinoma 256 and DMBA-induced mammary cancer of the rat. "
06/01/1967 - "Serum lipoproteins in rats with tumors induced by 9,10-dimethyl-1,2-benzanthracene and with transplanted Walker carcinosarcoma 256."
|9.||alpha-ketoglutaric acid (alpha-ketoglutarate)IBA
04/12/1979 - "II. Increase of alpha-ketoglutarate in whole blood and urine and hypoalbuminemia of rats bearing the solid rhabdomyosarcoma BA 1112 and the ascitic or solid forms of Walker-carcinoma 256 and Yoshida-sarcoma."
11/01/1960 - "Changes in liver tyrosine-alpha-ketoglutarate transaminase activity during growth of Walker carcinosarcoma 256."
06/01/1958 - "Growth-promoting properties of pyruvate oxal-acetate, and alpha-ketoglutarate for isolated Walker carcinosarcoma 256 cells."
|10.||Cytochromes c (Cytochrome c)IBA
|1.||Transplantation (Transplant Recipients)
01/01/1986 - "The bone metastases on SD rats were induced by intraarterial and intraosseous transplantation of Walker carcinosarcoma 256 B ascites cells. "
10/01/1992 - "Hypercalcemia was created by calcium infusions for 6 h, a high-calcium diet given to weanling rats for 3 weeks, and the transplantation of the Walker carcinosarcoma 256 cell line. "
04/01/1984 - "The phototoxicity of acridine orange and argon laser irradiation on Walker carcinosarcoma 256 stomach tumors was studied. "
01/01/1988 - "The photodynamic inactivations of Walker carcinosarcoma 256 stomach tumors by the concomitant use of acridine orange (AO) and argon laser, and by the combined use of hematoporphyrin derivatives (HPD) and dye laser were compared. "
|5.||Protein-Restricted Diet (Diet, Protein Restricted)